Pharmacological characterization of Ca2+ entry channels in endothelin-1-induced contraction of rat aorta using LOE 908 and SKandF 96365

British Journal of Pharmacology

Volumn 127, Issue 6, 1999, Pages 1388-1398

  Zhang, Xiao Feng ^a   Iwamuro, Yasushi ^a   Enoki, Taijiro ^a   Okazawa, Makoto ^a   Lee, Ken ^b   Komuro, Taro ^a   Minowa, Tetsuya ^a   Okamoto, Yasuo ^a   Hasegawa, Hiroshi ^a   Furutani, Hidekatsu ^a   Miwa, Soichi ^a   Masaki, Tomoh ^c  

^a KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Endothelin 1; Intracellular free Ca2+ concentration; LOE 908; Rat thoracic aorta; SKandF 96365; Vascular smooth muscle cells; Vasocontraction; Voltage independent calcium channel

Indexed keywords

1 [2 (4 METHOXYPHENYL) 2 [3 (4 METHOXYPHENYL)PROPOXY]ETHYL] 1H IMIDAZOLE; 2 (3,4 DIHYDRO 6,7 DIMETHOXY 1 ISOQUINOLINYL) 2 PHENYL N,N BIS[2 (2,3,4 TRIMETHOXYPHENYL)ETHYL]ACETAMIDE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; ENDOTHELIN 1; IONOMYCIN; NIFEDIPINE; THAPSIGARGIN; UNCLASSIFIED DRUG; 1 (2 (3 (4 METHOXYPHENYL)PROPOXY) 4 METHOXYPHENYLETHYL) 1H IMIDAZOLE; 1-(2-(3-(4-METHOXYPHENYL)PROPOXY)-4-METHOXYPHENYLETHYL)-1H-IMIDAZOLE; ACETAMIDE DERIVATIVE; CALCIUM; IMIDAZOLE DERIVATIVE; ISOQUINOLINE DERIVATIVE;

ANIMAL CELL; AORTA CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; ANIMAL; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; MALE; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; WISTAR RAT;

ACETAMIDES; ANIMALS; AORTA, THORACIC; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; IMIDAZOLES; ISOQUINOLINES; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; RATS; RATS, WISTAR;

EID: 0033161166     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702661     Document Type: Article

References (35)

1. Berridge, M.J. (1995). Capacitative calcium entry. Biochem. J., 312, 1-11.
2. 2+ antagonists. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S32-S35.
3. Chen, C. & Wagoner, P.K. (1991). Endothelin induces a nonselective cation current in vascular smooth muscle cells. Circ. Res., 69, 447-454.
4. D'Orleans-Juste, P., Finet, M., Nucci, G.D. & Vane, J.R. (1989). Pharmacology of endothelin-1 in isolated vessels: effect of nifedipine, methylene blue, hemoglobin, and gossypol. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S19-S22.
5. 2+ entry pathway in human endothelial cells by the isoquinoline derivative LOE 908. Br. J. Pharmacol., 119, 702-706.
6. Enoki, T., Miwa, S., Sakamoto, A., Minowa, T., Komuro, T., Kobayashi, S., Ninomiya, H. & Masaki, T. (1995). Long-lasting activation of cation current by low concentration of endothelin-1 in mouse fibroblasts and smooth muscle cells of rabbit aorta. Br. J. Pharmacol., 115, 479-485.
7. 2+ influx: how many mechanisms for how many channels? Trends Pharmacol. Sci., 15, 77-83.
8. Franzius, D., Hoth, M. & Penner, R. (1994). Non-specific effects of calcium entry antagonists in mast cells. Pflügers Arch., 428, 433-438.
9. 2+ channel in vascular smooth muscle. Proc. Natl. Acad. Sci. U.S.A., 86, 3915-3918.
10. Hoth, M. & Penner, R. (1992). Depletion of intracellular calcium stores activates a calcium current in mast cells. Nature, 355, 353-358.
11. 2+ level. Naunyn Schmiedebergs Arch. Pharmacol., 341, 80-87.
12. 1-adrenergic receptors in the rabbit portal vein. J. Physiol., 465, 427-448.
13. Inoue, Y., Oike, M., Nakao, K., Kitamura, K. & Kuriyama, H. (1990). Endothelin augments unitary calcium channel currents on the smooth muscle cell membrane of guinea-pig portal vein. J. Physiol. Lond., 423, 171-191.
14. 2+ entry: toward a proliferation or a simplification? FASEB J., 6, 3085-3091.
15. 2+-permeable nonselective cation channel by endothelin-1 in A7r5 cells. Br. J. Pharmacol., 124, 1541-1549.
16. 2+ channel blocker LOE 908. Br. J. Pharmacol., 126, 1107-1114.
17. Kasuya, Y., Takuwa, Y., Yanagisawa, M., Kimura, S., Goto, K. & Masaki, T. (1989). Endothelin-1 induces vasoconstriction through two functionally distinct pathways in porcine coronary artery: contribution of phosphoinositide turnover. Biochem. Biophys. Res. Commun., 161, 1049-1055.
18. 2+ stores in HL-60 cells: evidence that a cytochrome P-450 is not involved. Biochem. J., 302, 187-190.
19. Komuro, T., Miwa, S., Minowa, T., Okamoto, Y., Enoki, T., Ninomiya, H., Zhang, X.-F., Uemura, Y., Kikuchi, H. & Masaki, T. (1997a). The involvement of a novel mechanism distinct from the thrombin receptor in the vasocontraction induced by trypsin. Br. J. Pharmacol., 120, 851-856.
20. 2+-permeable nonselective cation channel in endothelin-1-induced contraction of rabbit aorta. J. Cardiovasc. Pharmacol., 30, 504-509.
21. 2+-permeable nonselective cation channel in rat aortic smooth muscle cells. Br. J. Pharmacol., 120, 1536-1544.
22. Minta, A., Kao, J.P.Y. & Tsien, R.Y. (1989). Fluorescent indicators for cytosolic calcium based on rhodamine and fluorescein chromophores. J. Biol. Chem., 264, 8171-8178.
23. 2+ influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane. Biochem. J., 300, 665-672.
24. 2+ influx. J. Mol. Cell. Cardiol., 28, 707-722.
25. Putney Jr, J.W. (1990). Capacitative calcium entry revisited. Cell Calcium, 11, 611-624.
26. Rubanyi, G.M. & Polokoff, M.A. (1994). Endothelins: molecular biology, biochemistry, pharmacology, physiology, and patho-physiology. Pharmacol. Rev., 46, 325-415.
27. Sakata, K., Ozaki, H., Kwon, S.-C. & Karaki, H. (1989). Effects of endothelin on the mechanical activity and cytosolic calcium levels of various types of smooth muscle. Br. J. Pharmacol., 98, 483-492.
28. Simpson, A.W., Stampfl, A. & Ashley, C.C. (1990). Evidence for receptor-mediated bivalent-cation entry in AI0 vascular smooth-muscle cells. Biochem J., 267, 277-280.
29. Takemura, H., Hughes, A.R., Thastrup, O. & Putney Jr, J.W. (1989). Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. J. Biol. Chem., 264, 12266-12271.
30. 2+-ATPase. Proc. Natl. Acad. Sci. U.S.A., 87, 2466-2470.
31. Turner, N.C., Power, R.F., Polak, J.M., Bloom, S.R. & Dollery, C.T. (1989). Endothelin-1-induced contractions of vascular and tracheal smooth muscle: effects of nicardipine and BRL 34915. J. Cardiovasc. Pharmacol., 13 (suppl. 5), S180-S182.
32. Van Renterghem, C., Vigne, P., Barhanin, J., Schmid Alliana, A., Frelin, C. & Lazdunski, M. (1988). Molecular mechanism of action of the vasoconstrictor peptide endothelin. Biochem. Biophys. Res. Commun., 157, 977-985.
33. Wayman, C.P., McFadzean, I., Gibson, A. & Tucker, J.F. (1996). Two distinct membrane currents activated by cyclopiazonic acid-induced calcium store depletion in single smooth muscle cells of the mouse anococcygeus. Br. J. Pharmacol., 117, 566-572.
34. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. & Masaki, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411-415.
35. 2+ entry pathway in endothelin-1-induced contraction and its suppression by nitric oxide. Eur. J. Pharmacol., 352, 237-245.